Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability

Abstract

Somatic frameshift mutations in some genes containing coding mononucleotide repeats (cMNRs) are well known characteristics of tumors with high microsatellite instability (MSI-H). We identified 22 novel and 11 known target genes containing cMNRs with a length of 10 or more nucleotides by using a systematic database search. Frameshift mutation analysis was performed with these 33 genes in 39 MSI-H and 24 microsatellite stable (MSS) colorectal carcinomas by assessing the mobility shifts of PCR products in gel electrophoresis and by sequencing. All the 39 MSI-H colorectal carcinomas, except one, showed mutations in more than one gene, while no mutations were found in 24 MSS colorectal carcinomas. Of these MSI-H tumors, 11 genes were mutated in more than 40%. The most frequently mutated novel genes were MARCKS (72%), FLJ11383 (74%) and TAF1B (82%). Biallelic inactivation in MARCKS and FLJ11383 was also frequent in MSI-H tumors. The observed mutation frequency of the 11 known target genes was compatible with that found by previous studies. The very high frequency of mutations, biallelic mutations and the predicted truncation of protein products suggests that mutations of MARCKS, FLJ11383 and TAF1B are selected, and play a role in the tumorigenesis of MSI-H colorectal carcinomas.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Bader S, Walker M, Hendrich B, Bird A, Bird C, Hooper M, Wyllie A . 1999 Oncogene 18: 8044–8047

  • Blackshear PJ . 1993 J. Biol. Chem. 268: 1501–1504

  • Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava SA . 1998 Cancer Res. 58: 5248–5257

  • Brooks G, Brooks SF, Gross MW . 1996 Carcinogenesis 17: 683–689

  • Brooks SF, Herget T, Broad S, Rozengurt E . 1992 J. Biol. Chem. 267: 14212–14218

  • Chen J, Heerdt BG, Augenlicht LH . 1995 Cancer Res. 55: 174–180

  • Choi SJ, Kim SK, Kim SJ, Koh CM, Park YS . 1998 J. Korean Cancer Assoc. 30: 527–535

  • Comai L, Zomerdijk JCBM, Beckmann H, Zhou S, Admon A, Tjian R . 1994 Science 266: 1966–1972

  • Duval A, Iacopetta B, Ranzani GN, Lothe RA, Thomas G, Hamelin R . 1999 Oncogene 18: 6806–6809

  • Eichler EE, Holden JJ, Popovich BW, Reiss AL, Snow K, Thibodeau SN, Richards CS, Ward PA, Nelson DL . 1994 Nat. Genet. 8: 88–94

  • Eshleman JR, Markowitz SD . 1996 Hum. Mol. Genet. 5: 1489–1494

  • Herget T, Brooks SF, Broad S, Rozengurt E . 1993 Proc. Natl. Acad. Sci. USA 90: 2945–2949

  • Kim JJ, Baek MJ, Kim L, Kim NG, Lee YC, Song SY, Noh SH, Kim H . 1999 Lab. Invest. 79: 1113–1120

  • Kim NG, Choi YR, Baek MJ, Kim YH, Kang H, Kim NK, Min JS, Kim H . 2001 Cancer Res. 61: 36–38

  • Ku JL, Yoon KA, Kim DY, Park JG . 1999 Eur. J. Cancer 35: 1724–1729

  • Lengauer C, Kinzler KW, Vogelstein B . 1997 Proc. Natl. Acad. Sci. USA 94: 2545–2550

  • Malkhosyan S, Rampino N, Yamamoto H, Perucho M . 1996 Nature 382: 499–500

  • Manenti S, Malecaze F, Chap H, Darbon JM . 1998 Cancer Res. 58: 1429–1434

  • Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKV . 1995 Science 268: 1336–1338

  • Mori Y, Yin J, Rashid A, Leggett BA, Young J, Simms L, Kuehl PM, Langenberg P, Meltzer SJ, Stein OC . 2001 Cancer Res. 61: 6046–6049

  • Ohmiya N, Matsumoto S, Yamamoto H, Baranovskaya S, Malkhosyan SR, Perucho M . 2001 Gene 272: 301–313

  • Park J, Betel D, Gryfe R, Michalickova K, Di Nicola N, Gallinger S, Hogue CW, Redston M . 2002 Cancer Res. 62: 1284–1288

  • Park JG, Oie HK, Sugarbaker PH, Henslee JG, Chen TR, Johnson BE, Gazdar A . 1987 Cancer Res. 47: 6710–6718

  • Parsons R, Myeroff LL, Liu B, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B . 1995 Cancer Res. 55: 5548–5550

  • Perucho M . 1996 Biol. Chem. 377: 675–684

  • Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M . 1997 Science 275: 967–969

  • Schwartz Jr S, Yamamoto H, Navarro M, Maestro M, Reventos J, Perucho M . 1999 Cancer Res. 59: 2995–3002

  • Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, Zou TT, Shi YO, Lei J, Cottrell J, Cymes K, Biden K, Simms L, Leggett B, Lynch PM, Frazier M, Powell SM, Harpaz N, Sugimura H, Young J, Meltzer SJ . 1996 Nat. Genet. 14: 255–257

  • Strand M, Prolla TA, Liskay RM, Petes TD . 1993 Nature 365: 274–276

  • Tran HT, Keen JD, Kricker M, Resnick MA, Gordenin DA . 1997 Mol. Cell. Biol. 17: 2859–2865

  • Woerner SM, Gebert J, Yuan YP, Sutter C, Ridder R, Bork P, Doeberitz MVK . 2001 Int. J. Cancer 93: 12–19

  • Yamamoto H, Sawai H, Perucho M . 1997 Cancer Res. 57: 4420–4426

  • Zhang L, Yu J, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B . 2001 Cancer Res. 61: 3801–3805

Download references

Acknowledgements

This work was supported by grants from Korean Science and Engineering Fund through the Cancer Metastasis Research Center at Yonsei University, BK21 projects for Medical Sciences, Yonsei University, and Ministry of Commerce, Industry and Energy (N03-990-5411-01-1-3), Republic of Korea. Part of this work was presented at the annual meeting of the American Association for Cancer Research, San Francisco, April 6–10, 2002.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hoguen Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, NG., Rhee, H., Li, L. et al. Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability. Oncogene 21, 5081–5087 (2002). https://doi.org/10.1038/sj.onc.1205703

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205703

Keywords

This article is cited by

Search

Quick links